Dental firm vVardis seeks up to $4.37B valuation in IPO
Dental health company vVardis is targeting a valuation of up to $4.37 billion in its upcoming United States initial public offering. The firm aims to raise up to $228.6 million by offering 9.5 million shares priced between $21 and $24 each on the NYSE.
Xurve View
Insights:
Xurve View
Dental firm vVardis is targeting a valuation of up to $4.37B in its upcoming United States IPO. The oral care company aims to raise up to $228.6M through a share offering. The listing highlights growing investor appetite for healthcare consumer brands entering public markets.
